Abivax is advancing obefazimod, a first-in-class oral therapy for UC and CD, with major upcoming data catalysts. Click here ...
Hyperfine, Inc. (NASDAQ:HYPR) Q4 2025 Earnings Call Transcript March 18, 2026 Hyperfine, Inc. beats earnings expectations. Reported EPS is $-0.06276, expectations were $-0.08. Operator: Hello, and ...
A cult classic rock drama blends coming of age heart with sex, drugs, and music, turning a box office flop into a timeless ...
Anne Hathaway made sure producers of The Devil Wears Prada 2 didn't feature "skeletal" models that were "alarmingly thin." ...
Gilead HPI licensing adds $35M now + $330M milestones; Phase 2 starts by 2026; strong cash runway. Click for this ASMB update ...
Some of The Leading Ladies From hospitality and fashion to art, entrepreneurship and giving back NEW YORK, NY, UNITED ...